Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;174(10):1464-1465.
doi: 10.7326/M21-3221. Epub 2021 Aug 17.

Selecting Treatments During an Infectious Disease Pandemic: Chasing the Evidence

Marshall J Glesby  1 , Roy M Gulick  1
Affiliations

Selecting Treatments During an Infectious Disease Pandemic: Chasing the Evidence

Marshall J Glesby et al. Ann Intern Med. 2021 Oct.

Abstract

In their article, Mehta and colleagues describe temporal trends in the use of hydroxychloroquine, remdesivir, and dexamethasone for the treatment of COVID-19 in patients hospitalized in the United States over a 13-month period beginning in February 2020. The editorialists discuss the findings and lessons learned from COVID-19 that will improve how we assess and disseminate emerging data leading to efficient, evidence-based implementation (or deimplementation) of treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-3221.

References

    1. Saag MS . Misguided use of hydroxychloroquine for COVID-19: the infusion of politics into science [Editorial]. JAMA. 2020;324:2161-2162. [PMID: ] doi:10.1001/jama.2020.22389 - DOI - PubMed
    1. Gautret P , Lagier JC , Parola P , et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949. [PMID: ] doi:10.1016/j.ijantimicag.2020.105949 - DOI - PMC - PubMed
    1. Voss A. Statement on IJAA paper. 3 April 2020. Accessed at www.isac.world/news-and-publications/official-isac-statement on 31 July 2021.
    1. Mehra MR , Desai SS , Kuy S , et al. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621 [Letter]. N Engl J Med. 2020;382:2582. [PMID: ] doi:10.1056/NEJMc2021225 - DOI - PMC - PubMed
    1. Mehra MR , Ruschitzka F , Patel AN . Retraction—hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395:1820. [PMID: ] doi:10.1016/S0140-6736(20)31324-6 - DOI - PMC - PubMed

MeSH terms